Aurinia Pharmaceuticals Inc.

(AUP:CA)

By |

Profile

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States followed by China.

Contact Information

Website: www.auriniapharma.com
Email: dbourgeault@auriniapharma.com
Main Phone: +1 250 708-4272
Address: 4464 Markham Street
Address 2: Suite 1203
State: BC
City / Town: Victoria
Country: CAN
Postal Code: V8Z 7X8

Issuer Information

Exchange: TSX
CEO: Richard M. Glickman
Employees: 39
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States followed by China.

Contact Information

Website: www.auriniapharma.com
Email: dbourgeault@auriniapharma.com
Main Phone: +1 250 708-4272
Address: 4464 Markham Street
Address 2: Suite 1203
State: BC
City / Town: Victoria
Country: CAN
Postal Code: V8Z 7X8

Issuer Information

Exchange: TSX
CEO: Richard M. Glickman
Employees: 39
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 8.91 $ 0.08 (0.91%)
Last Price 8.91 Change $ 0.08 Change % 0.91 Tick N/A
Bid 8.89 Bid Size 500.00 Ask 8.90 Ask Size 100.00
Open 8.83 High 9.10 Low 8.83 Prev Close 8.83
Last Trade Volume 30,720 52 Wk Hi 10.47 52 Wk Low 6.61
Market Cap 816.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 91,646,447.00 EPS (TTM) -0.98 PE Ratio N/A Exchange TSX
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 20.94 20.94 20.94 20.94
Low Target Price Estimate 12.8 12.8 12.8 12.8
Mean Target Price Estimate 16.27 16.27 16.27 16.27
Standard Deviation 3.2 3.2 3.2 3.2
Date of Most Recent Estimate 05/11/18 05/11/18 05/11/18 05/11/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 5
Moderate Buy 2 2 2 2
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.41 1.41 1.41 1.41